PLATFORM OVERVIEW
A unified computational ecosystem that bridges the gap between target identification and clinical-grade drug design. PanAum transforms static targets into dynamic therapeutic assets — bringing together the best of multi-omics, network biology, and generative chemistry under one automated roof.
Whole Genome Sequencing, Proteomics, and Epigenomics layers combined for deep biological context.
Five advanced metrics — Degree, Betweenness, Closeness, Eigenvector, and PageRank — for rigorous target scoring.
Specialized workflows for Small Molecules, Antibodies, PROTACs, and Novel Target classes.
Six automated stages — from evidence input to executive-ready reporting — with full scientific provenance.
See the Pipeline →